ARMP Armata Pharmaceuticals Earnings per share increase in current year

Armata Pharmaceuticals (ARMP) management relies on patent protection and strict FDA regulations. The annual growth of net income per share as a percentage demonstrates the results of this strategy, where the indicator value reaches 83.90. The company is creating a unique niche by combating superbugs through phage therapy, yet it faces capital shortages and uncertainty regarding clinical trial outcomes.

Earnings growth in current year: Armata Pharmaceuticals Inc (ARMP) for 07/04/2022 - 11/15/2026

Analytical breakdowns and data insights for company Armata Pharmaceuticals Inc (ARMP)

- price and consensus price forecast:

Stock Quotes Armata|ARMP - Price Target Chart

- market capitalization data:

Market Value Armata Pharmaceuticals, Inc.|ARMP - Total Company Value

- business book valuation details:

Net Asset Value per Share Armata Pharmaceuticals|ARMP - Book Capitalization|Market Value to Book Value Ratio armatapharma.com|ARMP - Company Total Assets

- debt and liquidity details:

Debt to Capital Armata Pharmaceuticals|ARMP - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Armata Pharmaceuticals, Inc.|ARMP - Company Aggregate Debts|Debts to Book Capitalization Armata Pharmaceuticals, Inc.|ARMP - Company Long-Term Debt|Company Short-Term Loans and Borrowings Armata Pharmaceuticals|Quick Liquidity Indicator armatapharma.com

- company profitability and valuation multiples indicators:

ARMP - Net Profit|Projected Future Earnings Armata Pharmaceuticals|ARMP - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Armata Pharmaceuticals|ARMP - PEG Multiple|EV/EBITDA Multiple Armata Pharmaceuticals Inc|ARMP - Operating profit before deduction of amortization|Earnings per share for the trailing year Armata Pharmaceuticals|ARMP - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months armatapharma.com|ARMP - Earnings growth in current year|Expected earnings per share trend next year Armata Pharmaceuticals

- sales volume and revenue information:

ARMP - Revenue and Sales Volume|Projected Sales Volume Armata|ARMP - Price-to-Revenue Ratio|Forward Price to Sales Armata Pharmaceuticals, Inc.

Fundamental valuation:Armata Pharmaceuticals

Signature product of Armata Pharmaceuticals, Inc.

This indicator measures the year-over-year dynamics of net earnings per share, allowing investors to assess real capital generation efficiency without market noise. By analyzing the annual change in earnings per share, one can determine whether the scientific achievements of Armata Pharmaceuticals (ARMP) in combating resistant bacteria are transforming into sustainable financial growth and an actual increase in shareholder value.

Main competitors

Net earnings per share growth this year Acurx